RBC Bearings Incorporated splits its revenue into 3 lines in its filings. The largest line in fiscal 2026, which ended Mar 28, 2026 was Industrial at $1.1 billion, 58% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2027
Sep 26, 2026
|
FY 2026
Mar 28, 2026
|
FY 2025
Mar 29, 2025
|
FY 2024
Mar 30, 2024
|
FY 2023
Apr 1, 2023
|
FY 2022
Apr 30, 2022
|
FY 2022
Apr 2, 2022
|
FY 2021
Apr 3, 2021
|
FY 2020
Mar 28, 2020
|
FY 2019
Mar 30, 2019
|
FY 2018
Mar 31, 2018
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2,024
|
1,871
|
1,636
|
1,560
|
1,469
|
943
|
943
|
609
|
727
|
703
|
675
|
| Industrial |
1,144
+7.9%
share 56.5%
|
1,083
+3.8%
share 57.9%
|
1,044
+0.2%
share 63.8%
|
1,041
+0.2%
share 66.7%
|
1,039
+85.1%
share 70.7%
|
—
|
561
+163.9%
share 59.5%
|
213
-3.3%
share 34.9%
|
220
+158.9%
share 30.2%
|
85
+11.7%
share 12.1%
|
76
share 11.3%
|
| Aerospace Defense |
880
+32.6%
share 43.5%
|
788
+32.9%
share 42.1%
|
593
+14.1%
share 36.2%
|
519
+20.7%
share 33.3%
|
430
+12.8%
share 29.3%
|
—
|
382
-3.7%
share 40.5%
|
396
-21.9%
share 65.1%
|
507
share 69.8%
|
—
|
—
|
| Aerospace |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
278
+16.5%
share 38.2%
|
238
+8.0%
share 33.9%
|
221
share 32.7%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Ball & Roller Bearings (SIC 3562)
- Listed as
- RBC (NYSE)
- Fiscal year ends
- March 29
- Headquarters
- Oxford, CT
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1324948
Source: SEC EDGAR filings. This is company-reported data, not investment advice.